THE PREVENTION OF ROTAVIRUS INFECTION: THE MODERN VIEW OF THE POSSIBILITY
https://doi.org/10.22627/2072-8107-2014-13-4-30-34
Abstract
Rotavirus is a major public health problem in all countries. The incidence of rotavirus infection is growing steadily in the Russian Federation and over the past 10 years increased by 7 times, amounting to 72 cases per 100,000 in 2010. The rotavirus vaccine was registered in the Russian Federation in 2012 and successfully applied from 2013. The vaccine used for more than 8 years and have enough experience on the efficacy and safety. Different foreign investigations have shown the herd immunity of the vaccine. The authors present data about the effectiveness and safety of vaccines, established during clinical studies of the foreign scientists.
About the Authors
T. A. Grechukha
Scientific Center of Children's Health, Moscow
Russian Federation
Russian Federation
D. A. Novikov
Scientific Center of Children's Health, Moscow
Russian Federation
Russian Federation
N. E. Tkachenko
Scientific Center of Children's Health, Moscow
Russian Federation
Russian Federation
L. S. Namazova-Baranova
Scientific Center of Children's Health, Moscow
Russian Federation
Russian Federation
References
1. Arvin A.M., Greenberg H.B. // Virology. — 2006; 344: 240—249.
2. Jeyaram H. et al. Emerging themes in rotavirus cell entry, genome organization, transcription and replication // Virus Res. — Vol. 101, Issue 1, с. 67—81, 2004.
3. Carl D. Kirkwood, Karen Boniface, Graeme L. Barnes. Distribution of Rotavirus Genotypes After Introduction of Rotavirus Vaccines, Rotarix and RotaTeq, into the National Immunization Program of Australia // The Pediatric Infectious Disease Journal. — V. 30 (1). — 2011: 48—53.
4. Adapted from: Podkolzin A.T. et al. Hospital-Based Surveillance of Rotavirus and Other Viral Agents of Diarrhea in Children and Adults in Russia, 2005—2007 // The Journal of Infectious Diseases. — 2009; 200: 228—33.
5. Подколзин А.Т., Петухов Д.Н., Веселова О.А. Данные о циркуляции ротавирусов группы А в РФ в зимний сезон 2011—2012 гг. Публикация Референс центра по мониторингу возбудителей кишечных инфекций доступна на интернет странице центра (www.epid-oki.ru). Podkolzin A.T., Petuhov D.N., Veselova O.A. Dannyie o tsirkulyatsii rotavirusov gruppyi A v RF v zimniy sezon 2011—2012 gg. Pub-likatsiya Referens tsentra po monitoringu vozbuditeley kishechnyih infektsiy dostupna na internet stranitse tsentra (www.epid-oki.ru). [Data on the circulation of group A rotaviruses in Russia in the winter season 2011—2012. Publication Reference center for monitoring agents of intestinal infections is available on the Internet page of the center] (In Russ.)
6. Florence T. Wang, T. Christopher Mast, Roberta J. Glass et al. Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United States // Pediatrics. — 2010 (208—213).
7. Резолюция участников совета экспертов по теме: «Бремя ротавирусной инфекции в Российской Федерации и потребность в специфической профилактике. Москва, декабрь 2011 года. Rezolyutsiya uchastnikov soveta ekspertov po teme: «Bremya rota-virusnoy infektsii v Rossiyskoy Federatsii i potrebnost v spetsificheskoy profilaktike. Moskva, dekabr 2011 goda. [Resolution of the Board of Experts of participants on the topic: "The burden of rotavirus infection in the Russian Federation and the need for specific prevention. Moscow, December 2011.] (In Russ.)
8. Костинов М.П. Экономическая эффективность вакцинации против ротавирусной инфекции в Российской Федерации // Журнал микробиологии и эпидемиологии. — 3 (2012). Kostinov M.P. Ekonomicheskaya effektivnost vaktsinatsii protiv rota-virusnoy infektsii v Rossiyskoy Federatsii [Cost-effectiveness of vaccination against rotavirus infection in the Russian Federation ] // Zhurnal Mikrobiologii i Epidemiologii. [Journal of Microbiology and Epidemiology] – 3 (2012). (In Russ.)
9. Roger I. Glass, Manish Patel, Umesh Parashar. Lessons From the US Rotavirus Vaccination Program // JAMA, October 19, 2011— Vol .306, № 15 (1701—1702).
10. Federico Martinon-Torres et al. Effectiveness of rotavirus vaccination in Spain // Human Vaccines. — 7:7, 757—761; July 2011.
11. M. Hemming, T. Vesikari. Genetic diversity of G1P[8] rotavirus VP7 and VP8 antigens in Finland over a 20-year period: No evidence for selection pressure by universal mass vaccination with RotaTeq vaccine // Infection, Genetics and Evolution. — 19 (2013). — Р. 51—58.
12. Mary Allen Staat, Daniel C. Payne et al. Effectiveness of Pentava-lent Rotavirus Vaccine Against Severe Disease // Pediatrics. — 2011 (267—274).
13. Ben A. Lopman, Daniel C. Payne, Jacqueline E. Tate et al. Post-li-censure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011 // Current Opinion in Virology. — 2012, 2:434—442.
14. Stephen B. Lambert, Cassandra E. Faux et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland // MJA. — 2009; 191: 157–160.
15. www.rotateq.com
16. Evan J. Anderson, Deanna B. Shippee et al. Indirect Protection of Adults From Rotavirus by Pediatric Rotavirus Vaccination // Clinical Infectious Diseases. — 2013; 56(6):755—760.
17. Ben A. Lopman, Aaron T. Curns, Catherine Yen et al. Infant Rotavirus Vaccination May Provide Indirect Protection to Older Children and Adults in the United States // The Journal of Infectious Diseases. — 2011; 204:980—986.
18. Manish M. Patel, Duncan Steele et al. Real-world Impact of Rotavirus Vaccination // The Pediatric Infectious Disease Journal. — Vol. 30, № 1, January 2011.
19. http://sites.path.org/rotavirusvaccine/rotavirus-advocacy-and-communications-toolkit/country-introduction-maps-and-list/
20. Ротавирусная инфекция. Как действительно защитить детей от тяжелых гастроэнтеритов? / Т.А Гречуха, М.Г. Галицкая, А.Г. Гайворонская, Л.С. Намазова-Баранова // Педиатрическая фармакология. — 2013; 10 (5): 14—17. Rotavirusnaya infektsiya. Kak deystvitelno zaschitit detey ot tyazhelyih gastroenteritov? [Rotavirus. How to really protect children from severe gastroenteritis? ] / T.A Grechuha, M.G. Galitskaya, A.G. Gayvoronskaya, L.S. Namazova-Baranova. // Pediatricheskaya Farmakologi-ya. [Pediatric pharmacology] — 2013; 10 (5): 14—17. (In Russ.)
21. Приказ Министерства здравоохранения Российской Федерации (Минздрав России) от 21 марта 2014 г. N 125н г. Москва Prikaz Ministerstva zdravoohraneniya Rossiyskoy Federatsii(Minzdrav Rossii) ot 21 marta 2014 g. N 125n g. Moskva/ [Order of the Ministry of Health of the Russian Federation (Russian Ministry of Health) on March 21, 2014 N 125n Moscow] (In Russ.).
Review
For citations:
Grechukha T.A., Novikov D.A., Tkachenko N.E., Namazova-Baranova L.S. THE PREVENTION OF ROTAVIRUS INFECTION: THE MODERN VIEW OF THE POSSIBILITY. CHILDREN INFECTIONS. 2014;13(4):30-34. (In Russ.) https://doi.org/10.22627/2072-8107-2014-13-4-30-34
Views:
2161
Email this article 